Functional precision oncology: Testing tumors with drugs to identify vulnerabilities and novel combinations DOI Creative Commons
Anthony Letai, Patrick Bhola, Alana L. Welm

и другие.

Cancer Cell, Год журнала: 2021, Номер 40(1), С. 26 - 35

Опубликована: Дек. 23, 2021

Functional precision medicine is a strategy whereby live tumor cells from affected individuals are directly perturbed with drugs to provide immediately translatable, personalized information guide therapy. The heterogeneity of human cancer has led the realization that approaches needed improve treatment outcomes. Precision oncology traditionally used static features dictate which therapies should be used. Static can include expression key targets or genomic analysis mutations identify therapeutically targetable "drivers." Although surprisingly small proportion derive clinical benefit approach, functional additional regarding vulnerabilities. We discuss emerging technologies for as well limitations and challenges in using these assays trials will necessary determine whether outcomes eventually become standard tool oncology.

Язык: Английский

Hallmarks of Cancer: New Dimensions DOI Open Access
Douglas Hanahan

Cancer Discovery, Год журнала: 2022, Номер 12(1), С. 31 - 46

Опубликована: Янв. 1, 2022

The hallmarks of cancer conceptualization is a heuristic tool for distilling the vast complexity phenotypes and genotypes into provisional set underlying principles. As knowledge mechanisms has progressed, other facets disease have emerged as potential refinements. Herein, prospect raised that phenotypic plasticity disrupted differentiation discrete hallmark capability, nonmutational epigenetic reprogramming polymorphic microbiomes both constitute distinctive enabling characteristics facilitate acquisition capabilities. Additionally, senescent cells, varying origins, may be added to roster functionally important cell types in tumor microenvironment. SIGNIFICANCE: Cancer daunting breadth scope its diversity, spanning genetics, tissue biology, pathology, response therapy. Ever more powerful experimental computational tools technologies are providing an avalanche "big data" about myriad manifestations diseases encompasses. integrative concept embodied helping distill this increasingly logical science, new dimensions presented perspective add value endeavor, fully understand development malignant progression, apply medicine.

Язык: Английский

Процитировано

3364

The molecular hallmarks of epigenetic control DOI
C. David Allis, Thomas Jenuwein

Nature Reviews Genetics, Год журнала: 2016, Номер 17(8), С. 487 - 500

Опубликована: Июнь 27, 2016

Язык: Английский

Процитировано

2325

The diverse roles of DNA methylation in mammalian development and disease DOI
Max Greenberg, Déborah Bourc’his

Nature Reviews Molecular Cell Biology, Год журнала: 2019, Номер 20(10), С. 590 - 607

Опубликована: Авг. 9, 2019

Язык: Английский

Процитировано

1716

Dynamics and function of DNA methylation in plants DOI
Huiming Zhang,

Zhaobo Lang,

Jian‐Kang Zhu

и другие.

Nature Reviews Molecular Cell Biology, Год журнала: 2018, Номер 19(8), С. 489 - 506

Опубликована: Май 21, 2018

Язык: Английский

Процитировано

1400

DNA Methylation in Mammals DOI Open Access

E. Li,

Yi Zhang

Cold Spring Harbor Perspectives in Biology, Год журнала: 2014, Номер 6(5), С. a019133 - a019133

Опубликована: Май 1, 2014

En Li1 and Yi Zhang2 1China Novartis Institutes for BioMedical Research, Pudong New Area, Shanghai 201203, China 2Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115 Correspondence: en.li{at}novartis.com

Язык: Английский

Процитировано

843

Histone Modifications and Cancer DOI Open Access
James E. Audia, Robert M. Campbell

Cold Spring Harbor Perspectives in Biology, Год журнала: 2016, Номер 8(4), С. a019521 - a019521

Опубликована: Апрель 1, 2016

Histone posttranslational modifications represent a versatile set of epigenetic marks involved not only in dynamic cellular processes, such as transcription and DNA repair, but also the stable maintenance repressive chromatin. In this article, we review many key newly identified histone known to be deregulated cancer how impacts function. The latter part article addresses challenges current status drug development process it applies therapeutics.

Язык: Английский

Процитировано

839

Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma DOI
Rui‐Hua Xu, Wei Wei, Michał Krawczyk

и другие.

Nature Materials, Год журнала: 2017, Номер 16(11), С. 1155 - 1161

Опубликована: Окт. 9, 2017

Язык: Английский

Процитировано

746

Genomic Imprinting in Mammals DOI Open Access

Denise P. Barlow,

Marisa S. Bartolomei

Cold Spring Harbor Perspectives in Biology, Год журнала: 2014, Номер 6(2), С. a018382 - a018382

Опубликована: Фев. 1, 2014

Denise P. Barlow1 and Marisa S. Bartolomei2 1CeMM Research Center for Molecular Medicine of the Austrian Academy Sciences, CeMM, 1090 Vienna, Austria 2Department Cell Developmental Biology, University Pennsylvania Perelman School Medicine, Philadelphia, 19104-6148 Correspondence: dbarlow{at}cemm.oeaw.ac.at bartolom{at}mail.med.upenn.edu

Язык: Английский

Процитировано

663

Navigating the DNA methylation landscape of cancer DOI Creative Commons
Atsuya Nishiyama, Makoto Nakanishi

Trends in Genetics, Год журнала: 2021, Номер 37(11), С. 1012 - 1027

Опубликована: Июнь 10, 2021

DNA methylation is an important epigenetic modification that defines the properties of cells. Genome-wide hypomethylation, as well hypermethylation CpG islands associated with tumor suppressor genes and developmental regulators, are characteristics cancer cells.DNA methyltransferases normally exist in inactive form their localization activation regulated by interaction unique histone modifications at sites.Changes patterns carcinogenesis progress gradually cell proliferation. hypomethylation found blocks called partially methylated domains (PMDs) it frequently occurs solo-WCGW sequences have no nearby adjacent to A or C.CpG island primarily targets promoters characterized low gene expression marked H3K27m3, replacement ensuring more stable repression. a chemical type lineage through control genome stability. Disruption mechanisms causes variety diseases, including cancer. Cancer cells aberrant (i.e., genome-wide site-specific hypermethylation), mainly targeting regulatory elements. In particular, early findings (TSGs) led proposal model which promotes cellular oncogenesis TSGs silencing. However, recent analyses revealed this classical needs be reconsidered. review, we will discuss molecular abnormalities therapeutic potential. plays role regulation [1.Yisraeli J. et al.Muscle-specific chimeric actin gene.Cell. 1986; 46: 409-416Abstract Full Text PDF PubMed Scopus (0) Google Scholar, 2.Busslinger M. al.DNA globin expression.Cell. 1983; 34: 197-206Abstract 3.Siegfried Z. represses transcription vivo.Nat. Genet. 1999; 22: 203-206Crossref (268) Scholar], genomic imprinting [4.Li E. al.Role for imprinting.Nature. 1993; 366: 362-365Crossref (1684) 5.Stöger R. al.Maternal-specific imprinted mouse Igf2r locus identifies expressed carrying signal.Cell. 73: 61-71Abstract 6.Ferguson-Smith A.C. al.Parental-origin-specific H19 gene.Nature. 362: 751-755Crossref X chromosome inactivation [7.Mohandas T. al.Reactivation human chromosome: evidence methylation.Science. 1981; 211: 393-396Crossref Scholar,8.Wolf S.F. al.Methylation hypoxanthine phosphoribosyltransferase on implications X-chromosome inactivation.Proc. Natl. Acad. Sci. U. S. A. 1984; 81: 2806-2810Crossref transposon (see Glossary) silencing [9.Walsh C.P. al.Transcription IAP endogenous retroviruses constrained cytosine methylation.Nat. 1998; 20: 116-117Crossref (808) stability [10.Eden al.Chromosomal instability tumors promoted hypomethylation.Science. 2003; 300: 455Crossref (1008) Scholar,11.Karpf A.R. Matsui Genetic disruption methyltransferase enzymes induces chromosomal cells.Cancer Res. 2005; 65: 8635-8639Crossref (190) Scholar]. catalyzed three enzymes, DNMT1, DNMT3A, DNMT3B (Figure 1). De novo (DNMTs) DNMT3A 3B (Box 1), while established maintained daughter maintenance mechanism during proliferation 2). Both de normal development. DNMT1 DNMT3A/3B double knockout (KO) embryos show significant growth inhibition lethal before mid-gestation [12.Li al.Targeted mutation results embryonic lethality.Cell. 1992; 69: 915-926Abstract (3073) Scholar,13.Okano Dnmt3a Dnmt3b essential mammalian development.Cell. 99: 247-257Abstract (4122) contrast, not necessarily required stem (ES) cells; even when completely lost combined KO DNMTs Dnmt1, Dnmt3a, Dnmt3b, there minimal change phenotype undifferentiated ES [14.Tsumura al.Maintenance self-renewal ability absence Dnmt3b.Genes Cells. 2006; 11: 805-814Crossref (380) Although modification, also several pathways demethylation these play various biological contexts 3). cells, most methylated, but shores (the region within 2 kb islands) exceptionally hypomethylated [15.Irizarry R.A. al.The colon methylome shows similar hypo- conserved tissue-specific shores.Nat. 2009; 41: 178-186Crossref (1528) Scholar,16.Doi al.Differential tissue- cancer-specific distinguishes induced pluripotent fibroblasts.Nat. 1350-1353Crossref (892) Many regions function elements regulate expression, such enhancers. addition, systematic analysis unmethylated ligands has binding many factors [17.Yin Y. al.Impact specificities factors.Science. 2017; 356eaaj2239Crossref (373) Recently, broad were reported canyons [18.Jeong al.Large Dnmt3a.Nat. 2014; 17-23Crossref (203) Scholar] valleys [19.Xie W. al.Epigenomic multilineage differentiation cells.Cell. 2013; 153: 1134-1148Abstract (475) either active mark H3K4me3 inhibitory H3K27me3.Figure 2Regulatory activity localization.Show full caption(A) H3, exists autoinhibitory state, ATRX-DNMT3A-DNMT3L (ADD) domain interacts catalytic (CD) inhibit binding. H3K4me0 ADD break autoinhibition activate DNMT3A. release H3K36me3 Pro-Trp-Trp-Pro (PWWP) promote body. It been H3K36Kme2 similarly regulates intergenic PWWP domain. (B) DNMT3A2 DNMT3B3, catalytically subunits, heterotetrameric 3B3-3A2-3A2-3B3. One two catalytic-like DNMT3B3 acidic patch nucleosome core particle, leading linker DNA. The chromatin (DNMT) complexes methylation, indicating importance patch, addition H3K36me2 me3.View Large Image Figure ViewerDownload Hi-res image Download (PPT)Box 1De methylationMammalian sites methyltransferases, [13.Okano Scholar,125.Okano al.Cloning characterization family novel (cytosine-5) methyltransferases.Nat. 19: 219-220Crossref (1206) DNMT3 proteins composed N terminal region, central enzyme C 1) [126.Goll M.G. Bestor T.H. Eukaryotic methyltransferases.Annu. Rev. Biochem. 74: 481-514Crossref (1492) roles target enzymatic activity. proper [127.Ge Y.-Z. al.Chromatin domain.J. Biol. Chem. 2004; 279: 25447-25454Abstract (148) acts reader module recognize bind histones [128.Dhayalan reads 3 lysine 36 trimethylation guides methylation.J. 2010; 285: 26114-26120Abstract (330) Histone enriches body actively transcribed undergoing catalysis SETD2 protein (also RNAPII subunit B1), binds RNA polymerase II [129.Wagner E.J. Carpenter P.B. Understanding language Lys36 H3.Nat. Mol. Cell 2012; 13: 115-126Crossref (534) 130.Kizer K.O. al.A Set2 mediates couples H3 K36 transcript elongation.Mol. Cell. 25: 3305-3316Crossref (329) 131.Krogan N.J. Saccharomyces cerevisiae linked transcriptional elongation II.Mol. 23: 4207-4218Crossref (492) [132.Baubec al.Genomic profiling reveals genic methylation.Nature. 2015; 520: 243-247Crossref (350) Transcription- H3K36me3-mediated establishment oocyte [133.Xu Q. al.SETD2 maternal epigenome, development.Nat. 2019; 51: 844-856Crossref (64) Several studies shown differently. NSD1 NSD2 K36me2 using mesenchymal (MSCs) showed depends MSCs [134.Weinberg D.N. recruits shapes landscape.Nature. 573: 281-286Crossref (97) NSD1-mediated recently male germlines [135.Shirane K. al.NSD1-deposited directs germline counteracts Polycomb-associated silencing.Nat. 2020; 52: 1088-1098Crossref (15) Thus, H3K36me2-enriched H3K36me3-enriched bodies may specify DNMT3B, respectively, domain.The recognizes unmodified 4 [136.Ooi S.K. al.DNMT3L connects DNA.Nature. 2007; 448: 714-717Crossref (1040) crystal structure complex amino-terminal tail specific H3K4me0, H3K4me2 [137.Otani al.Structural basis recognition H3K4 status 3A ATRX–DNMT3–DNMT3L domain.EMBO Rep. 10: 1235-1241Crossref (250) 138.Guo X. insight into H3-induced DNMT3A.Nature. 517: 640-644Crossref (188) 139.Noh K.-M. al.Engineering histone-recognition alters landscape phenotypic features ESCs.Mol. 59: 89-103Abstract These consistent fact distribution mutually exclusive [138.Guo 140.Zhang Dnmt3a/3L guided tail.Nucleic Acids 38: 4246-4253Crossref (243) 141.Li B.-Z. al.Histone tails allosterically activating methyltransferase.Cell 2011; 21: 1172-1181Crossref (81) 142.Guibert al.Global erasure primordial germ cells.Genome 633-641Crossref (224) Moreover, stimulates vitro Scholar,140.Zhang Scholar,141.Li tail, directly inhibits (CD). H3K4me3, disrupts ADD-CD cancels 2A) This would ensure suppression unfavorable H3K4me3-marked promoter, recruited.Figure 3Ubiquitin-like, containing PHD RING finger 1 (UHRF1)-dependent ubiquitin signaling orchestrates methylation.Show captionDuring replication, converted hemi-methylated only parent strand methylated. UHRF1 specifically Lys residues terminus PCNA-associated factor 15 (PAF15) dual monoubiquitylation. Ubiquitinated PAF15 RFTS DNMT1. Hemi-methylated left after passage replication machinery fully DNA, probably via UHRF1-dependent monoubiquitination H3. between USP7 indicates act deubiquitinating antagonizes UHRF1.View 2Maintenance methylationProper require factors. Early demonstrated colocalizes PCNA foci [143.Chuang L. al.Human DNA-(cytosine-5) methyltransferase-PCNA p21WAF1.Science. 1997; 277: 1996-2000Crossref (755) later was DNMT1/PCNA [144.Spada F. al.DNMT1 its cells.J. 176: 565-571Crossref (145) Scholar,145.Easwaran H.P. al.Replication-independent loading Dnmt1 G2 M phases.EMBO 5: 1181-1186Crossref (130) Ubiquitin-like, (UHRF1), ICPB90 humans Np95 mice, critical [116.Sharif SRA inheritance recruiting 450: 908-912Crossref (830) Scholar,117.Bostick al.UHRF1 Plays maintaining cells.Science. 317: 1760-1764Crossref (867) SET- RING-associated (SRA) [146.Arita al.Recognition base-flipping mechanism.Nature. 2008; 455: 818-821Crossref (335) 147.Hashimoto H. flips 5-methylcytosine out helix.Nature. 826-829Crossref (300) 148.Avvakumov G.V. UHRF1.Nature. 822-825Crossref (331) accumulates recruit Recent indicated E3 ligase efficient methylation. Upon SRA-mediated mono-ubiquitylates Lys14-, Lys18, and/or 23 [115.Nishiyama al.Uhrf1-dependent H3K23 ubiquitylation replication.Nature. 502: 249-253Crossref (206) Scholar,149.Ishiyama al.Structure complexed two-mono-ubiquitin maintenance.Mol. 68: 350-360Abstract Scholar,150.Qin requires interacting motif (UIM) ubiquitination.Cell 911-929Crossref (127) Hemi-methyl-DNA accessibility [120.Harrison J.S. al.Hemi-methylated allosteric UHRF1.eLife. 2016; 5e17101Crossref Scholar,151.Fang opens closed conformation facilitate recognition.Nat. Commun. 7: 11197Crossref (66) Ubiquitin-like (UBL) contributes E2 ubiquitin-conjugating Ubch5a/UBE2D1 [123.Foster B.M. al.Critical UBL stimulating toward chromatin.Mol. 2018; 72: 739-752Abstract (31) Scholar,124.DaRosa P.A. bifunctional DNA-dependent ubiquitylation.Mol. 753-765Abstract (29) Multiple mono-ubiquitylated turn recognized bound modules DNMT1-RFTS [118.Li mechanistic insights UHRF1-mediated methylation.Nucleic 3218-3231Crossref (53) previously recruitment [152.Leonhardt sequence nuclei.Cell. 71: 865-873Abstract (784) proposed pocket [153.Takeshita (Dnmt1).Proc. 108: 9055-9059Crossref Scholar,154.Syeda focus (RFTS) DNA-competitive inhibitor Dnmt1.J. 286: 15344-15351Abstract (76) Importantly, enhances [149.Ishiyama presumably gross conformational opening site. data indicate ubiquitylated platform DNMT1.Recently, emerged another substrate multiple mono-ubiquitylation [121.Nishiyama al.Two distinct modes 1222Crossref (25) Scholar,155.Karg al.Ubiquitome ubiquitination 429: 3814-3824Crossref (19) 2VRTK5, extreme PAF15, manner ARTK suggesting recognizing end proteins. During S phase, undergoes evolutionarily replication-coupled front face inner ring exits clamp from back [156.March al.p15PAF modulates sliding surface.Nucleic 9816-9828Crossref (7) could PCNA, facilitating 3).Box 3DNA demethylationDuring development, pattern fluctuates dynamically [142.Guibert Scholar,157.Hajkova P. dynamics reprogramming line.Nature. 452: 877-881Crossref (482) Scholar,158.Hackett J.A. al.Germline imprint 5-hydroxymethylcytosine.Science. 339: 448-452Crossref (511) particularly preimplantation (PGC) setting up states erasing parental-origin-specific imprints developing PGCs [159.Lee al.Erasing memory clone produced day 11.5 cells.Development. 2002; 129: 1807-1817Crossref (50) Scholar,160.Hill demethylation, Tet 5-hydroxymethylcytosine reprogramming: emerging story.Genomics. 104: 324-333Crossref (101) different pathways: (i) replication-dependent dilution marks [161.Kagiwada al.Replication-coupled passive mice.EMBO 32: 340-353Crossref (197) 162.Ohno 140: 2892-2903Crossref (52) 163.Seisenberger cells.Mol. 48: 849-862Abstract (575) 164.Kurimoto al.Complex orchestrated Blimp1 specification mice.Gene Dev. 1617-1635Crossref (ii) Ten-eleven Translocation (TET)-dependent [165.Yamaguchi Tet1 504: 460-464Crossref 166.Yamaguchi al.Tet1 controls meiosis regulating meiotic expression.Nature. 492: 443-447Crossref (182) 167.Wu Zhang Reversing methylati

Язык: Английский

Процитировано

646

Circular ecDNA promotes accessible chromatin and high oncogene expression DOI
Sihan Wu, Kristen M. Turner, Nam Nguyen

и другие.

Nature, Год журнала: 2019, Номер 575(7784), С. 699 - 703

Опубликована: Ноя. 20, 2019

Язык: Английский

Процитировано

493